Company Filing History:

13 out of 940

Fujisawa Pharmaceutical Company, Ltd.

Years Active: 1989-2008

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7317107 - Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity (2008-01-08),

2. 7183306 - Pyrazole derivatives (2007-02-27),

3. 7064144 - Imidazole derivatives as adenosine deaminase inhibitors (2006-06-20),

4. 6927230 - Triazole derivatives (2005-08-09),

5. 6908940 - Imidazole compounds and their use as adenosine deaminase inhibitors (2005-06-21),

6. 6596738 - Heterocyclic compound, composition and method for inhibiting adenosine deaminase (2003-07-22),

7. 6359145 - Imidazole compounds (2002-03-19),

8. 6316485 - 1,5-diphenylpyrazole derivatives (2001-11-13),

9. 5739130 - Heterotricyclic derivatives, process for their preparation and (1998-04-14),

10. 5583135 - Heterotricyclic derivatives, process for their preparation and (1996-12-10),

11. 5571810 - Thiophene derivatives (1996-11-05),

12. 5134142 - Pyrazole derivatives, and pharmaceutical composition comprising the same (1992-07-28),

13. 5098927 - Antiretroviral agent, method of use thereas, and method of preparation (1992-03-24),

14. 4963536 - Diphosphonic acid compounds, and pharmaceutical composition comprising (1990-10-16),

15. 4889851 - Benzothiadiazine compounds, and pharmaceutical composition comprising (1989-12-26),

Title: Katsuya Nakamura: Innovator in Pharmaceutical Chemistry

Introduction

Katsuya Nakamura is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 16 patents. His work primarily focuses on compounds that have therapeutic applications, particularly in the area of adenosine deaminase inhibition.

Latest Patents

Among his latest patents, Nakamura has developed imidazole 4-carboxamide compounds that exhibit adenosine deaminase inhibiting activity. These compounds are represented by a specific formula, where R can be optionally substituted aryl or heteroaryl, lower alkyl, hydroxy, or protected hydroxy. The compounds are particularly useful for treating and preventing diseases where adenosine plays a critical role. Additionally, he has worked on pyrazole derivatives, which include compounds where R can be hydrogen or lower alkyl.

Career Highlights

Throughout his career, Katsuya Nakamura has been associated with notable companies in the pharmaceutical industry, including Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Nakamura has collaborated with esteemed colleagues such as Kiyoshi Tsuji and Tadashi Terasaka. These partnerships have fostered innovation and have been instrumental in the development of his patented compounds.

Conclusion

Katsuya Nakamura's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, paving the way for new therapeutic options.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.